Shanghai, China—DuPont Nutrition & Biosciences today announced in a press release its intent to enter into a strategic collaboration with BY-HEALTH, a consumer healthcare company in China.
The collaboration would focus on R&D of probiotic dietary supplements with new functions, ingredients, and technologies, including joint research on intestinal microecology.
Related: DuPont Opens State-of-the-Art Probiotics Fermentation Unit
DuPont Describes Advantages of Third-Party Evaluation of Probiotic Products
Probiotic Use Could Cut Costs of Medical Bills, Lost Productivity by $1.4B
“At DuPont, we’re focused on improving people’s everyday lives, and China is an important consumer market. With our expertise within probiotics and microbiome science, we’re delighted to partner with one of the leading consumer health care companies in Asia Pacific to develop new probiotics-based products to satisfy consumers’ growing demand for natural health and wellness solutions,” said Anders Grøn, DuPont Vice President & Global Business Director – Probiotics, HMOs, & Fibers.